Budget Amount *help |
¥20,410,000 (Direct Cost: ¥15,700,000、Indirect Cost: ¥4,710,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2011: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2010: ¥12,350,000 (Direct Cost: ¥9,500,000、Indirect Cost: ¥2,850,000)
|
Research Abstract |
To confer the antiviral potential against influenza virus to pigs as a mixing vessel for creating a “new” influenza virus, we investigated the ability of Siglecs to inhibit influenza virus infection in vitro and in vivo by using Madin-Derby canine kidney (MDCK) cells and transgenic mice expressing a soluble form of human Siglec molecules. The transformed MDCK cells showed a significant resistance, but not the transgenic mice
|